Borealis Biosciences Canada, Inc.
Registration:
1
of
1
(2025-11-13
to
present)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Seeking provincial funding from the government of British Columbia, in connection with Borealis Bioscience's application to the federal government's Strategic Response Fund (SRF), to support research and development activities and building of RNA therapeutics manufacturing capabilities for its oligonucleotide (siRNA/ASO) delivery platform to the kidney and potentially other organs.
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health, Science and Technology
|